LOS ANGELES CAPITAL MANAGEMENT LLC
Position in AKBA — Akebia Therapeutics, Inc.
CIK 1177206
LOS ANGELES, CA
Position in AKBA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$835,818
+$788,151 QoQ
Shares Held
601,308
+1931.0% QoQ
Ownership
0.217%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
7 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $63,936,746 across 33 Drug Manufacturers - Specialty & Generic names. AKBA ranks #11 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
149,111 | $19,643,883 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
29,124 | $17,269,949 | |
| 3 | ZTS |
Zoetis Inc.
|
59,483 | $7,031,485 | |
| 4 | PAHC |
Phibro Animal Health Corp
|
92,067 | $5,092,225 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
82,169 | $2,504,511 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
509,247 | $1,787,456 | |
| 7 | VTRS |
Viatris Inc
|
126,728 | $1,712,095 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
21,817 | $1,677,727 |
All Filings in AKBA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $835,818 | 601,308 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $47,667 | 29,607 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $80,827 | 29,607 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $97,344 | 26,743 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $51,212 | 26,673 | Shares | Sole | 2025-05-05 | |
| 2020-09-30 | $66,640 | 26,550 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $193,379 | 14,240 | Shares | Sole | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||